GnRH agonist (buserelin) or HCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study

By Engmann Lawrence   Benadiva Claudio  

Human Reproduction, Vol. 20, Iss. 11, 2005-11 ,pp. : 3258-3260

Oxford University Press

Access to resources Recommend Favorite

Reply: GnRH agonist (buserelin) or hCG for ovulation induction in gnRH antagonist IVF/ICSI cycles: a prospective randomized study

By Humaidan Peter  

Human Reproduction, Vol. 20, Iss. 11, 2005-11 ,pp. : 3260-3260

Oxford University Press

Access to resources Recommend Favorite

Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study

By Cédrin-Durnerin I.  

Human Reproduction, Vol. 19, Iss. 9, 2004-09 ,pp. : 1979-1984

Oxford University Press

Access to resources Recommend Favorite

GnRH agonist versus GnRH antagonist in oocyte donation cycles: a prospective randomized study

By Prapas N.  

Human Reproduction, Vol. 20, Iss. 6, 2005-06 ,pp. : 1516-1520

Oxford University Press

Access to resources Recommend Favorite

GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study †

By Papanikolaou E.G.   Pados G.   Grimbizis G.   Bili E.   Kyriazi L.   Polyzos N.P.   Humaidan P.   Tournaye H.   Tarlatzis B.  

Human Reproduction, Vol. 27, Iss. 6, 2012-06 ,pp. : 1822-1828

Oxford University Press

Access to resources Recommend Favorite